Black Rock Inc. Relmada Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 573,314 shares of RLMD stock, worth $217,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares

573,314

Previous 578,188 0.84%

Holding current value

$217,859

Previous $2.69 Million 36.05%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.93 - $4.94 $14,280 - $24,077	-4,874 Reduced 0.84%	573,314 $1.72 Million
Q1 2024 May 10, 2024	BUY	$3.1 - $6.8 $16,879 - $37,026	5,445 Added 0.95%	578,188 $2.69 Million
Q4 2023 Feb 13, 2024	SELL	$2.45 - $4.22 $3,341 - $5,756	-1,364 Reduced 0.24%	572,743 $2.37 Million
Q3 2023 Nov 13, 2023	SELL	$2.48 - $3.79 $77,244 - $118,047	-31,147 Reduced 5.15%	574,107 $1.72 Million
Q2 2023 Aug 11, 2023	SELL	$2.22 - $3.54 $2.74 Million - $4.37 Million	-1,233,163 Reduced 67.08%	605,254 $1.49 Million
Q1 2023 May 12, 2023	SELL	$2.24 - $4.76 $55,384 - $117,691	-24,725 Reduced 1.33%	1,838,417 $4.15 Million
Q4 2022 Feb 13, 2023	SELL	$2.17 - $35.84 $629,703 - $10.4 Million	-290,186 Reduced 13.48%	1,863,142 $6.5 Million
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $7,631 - $15,437	417 Added 0.02%	2,153,328 $79.7 Million
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $3.3 Million - $6.07 Million	200,103 Added 10.25%	2,152,911 $40.9 Million
Q1 2022 May 12, 2022	BUY	$16.72 - $26.99 $9.49 Million - $15.3 Million	567,573 Added 40.97%	1,952,808 $52.7 Million
Q4 2021 Feb 10, 2022	BUY	$16.93 - $26.82 $2.96 Million - $4.69 Million	174,994 Added 14.46%	1,385,235 $31.2 Million
Q3 2021 Nov 09, 2021	SELL	$21.86 - $34.77 $5.68 Million - $9.04 Million	-259,866 Reduced 17.68%	1,210,241 $31.7 Million
Q2 2021 Aug 11, 2021	BUY	$29.55 - $39.15 $43.4 Million - $57.6 Million	1,470,107 New	1,470,107 $47.1 Million

Others Institutions Holding RLMD

# of Institutions

Shares Held

12.3M

Call Options Held

229K

Put Options Held

138K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account